Clinical studies of incretin-based therapy in type 1 diabetes: a new approach of antidiabetic drugs?
10.3760/cma.j.issn.1000-6699.2014.11.001
- VernacularTitle:肠促胰素在1型糖尿病中的临床研究:1型糖尿病降糖新方案?
- Author:
Chuqing CAO
;
Yufei XIANG
;
Zhiguang ZHOU
- Publication Type:Journal Article
- Keywords:
Incretin;
Diabetes mellitus,type 1
- From:
Chinese Journal of Endocrinology and Metabolism
2014;30(11):943-949
- CountryChina
- Language:Chinese
-
Abstract:
Incretin-based therapies are now being widely used in type 2 diabetes as a new type of antidiabetic drugs,with their efficacy and safety having been confirmed.However,there are relatively few researches carried out in type 1 diabetes.A variety of clinical studies (mainly in type 2 diabetes) have shown that incretin-based therapy could effectively improve glucose control.In this article,the clinieal application of incretin-based therapy in type 1 diabetes will be reviewed and commented from the prospective of clinical studies,combined with animal experiments.
